Who Paid My Doc
A Phase 3B, Multicenter, Single-Arm, Open-Label Study Evaluating the E
Research payments
$705,587
Through program year 2025, $705,587 in research payments was reported against A Phase 3B, Multicenter, Single-Arm, Open-Label Study Evaluating the E, across 247 payments, paid by ViiV Healthcare Company.
- Paid by
- ViiV Healthcare Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $528,660 | 201 |
| 2024 | Research | $27,615 | 18 |
| 2023 | Research | $149,312 | 28 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Robert Grossberg Bronx, NY Named on 19 payments
- Ashraf Zadshir Rancho Mirage, CA Named on 19 payments
- Cornelius Van Dam Greensboro, NC Named on 18 payments
- Archana Asundi Boston, MA Named on 18 payments
- Franco Felizarta Bakersfield, CA Named on 13 payments
- Sara Bares Omaha, NE Named on 13 payments
- Cheryl Newman Fort Gordon, GA Named on 12 payments
- Moti Ramgopal Fort Pierce, FL Named on 10 payments
- Alexandra Dretler Decatur, GA Named on 10 payments
- Olayemi Osiyemi West Palm Beach, FL Named on 8 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.